The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:329, February 2006
doi: 10.1176/appi.ajp.163.2.329
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by GOLDNEY, R. D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by GOLDNEY, R. D.
Related Collections
* Bipolar Disorder
* Other Ethics Issues
* Suicide

Letter to the Editor

Suicide Risk in Placebo-Controlled Trials of Bipolar Disorder

ROBERT D. GOLDNEY, M.D.
Adelaide, South Australia, Australia

To the Editor:

Jitschak G. Storosum, M.D., Ph.D., and colleagues (1) addressed the important issue of placebo-controlled trials of bipolar disorder and noted that there are ethical problems in using placebo when effective treatments are available, particularly when there is a risk of suicidal behavior. They noted in the abstract that concern about the risk of suicidal behavior "should not be an argument against the conduct of placebo-controlled trials for these indications, provided that appropriate precautions are taken" (p. 799). However, is such a conclusion scientifically credible, logical, or, indeed, ethical when seven of 11 studies examining the treatment of manic episodes and all four studies of the prevention of manic/depressive episodes excluded suicidal patients? Perhaps "appropriate precautions" implies not including those who are suicidal, which—contrary to the assertion in the authors’ conclusion—seems to indicate that there is concern about the risk of suicidal behavior in such placebo-controlled trials.

Reference

  1. Storosum JG, Wohlfarth T, Gispen-de Wied CC, Linszen DH, Gersons BPR, van Zwieten BJ, van den Brink W: Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode. Am J Psychiatry 2005; 162:799–802[Abstract/Free Full Text]




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by GOLDNEY, R. D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by GOLDNEY, R. D.
Related Collections
* Bipolar Disorder
* Other Ethics Issues
* Suicide


Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org